Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/1991
07/02/1991US5028424 Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells
07/02/1991US5028422 Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
07/02/1991US5028421 Method of treating birds
07/02/1991US5028420 Muteins of tumor necrosis factor
07/02/1991CA1285507C Hybrid interferons
07/02/1991CA1285480C Plasma exchange composition
07/02/1991CA1285479C Immunostimulant agents
07/02/1991CA1285478C Stable composition of interleukin-2
07/02/1991CA1285423C Method for increasing the feed intake of an animal
06/1991
06/30/1991WO1991009960A1 Hybrid protein c
06/29/1991WO1991009875A1 Monoclonal antibody, hybridomas, their production and use
06/29/1991CA2069872A1 Monoclonal antibody, hybridomas, their production and use
06/28/1991WO1991009974A1 Diagnostic probe for detecting human stomach cancer
06/28/1991WO1991009611A1 Drug for preventing and treating fish diseases
06/28/1991CA2072602A1 Drug for preventing and treating fish diseases
06/28/1991CA2070995A1 Diagnostic probe for detecting human stomach cancer
06/27/1991WO1991009137A1 Recombinant thyrotropin receptor
06/27/1991WO1991009124A1 Variants of pai-2
06/27/1991WO1991009123A1 Soluble cd4 having a decreased affinity for mhc class ii antigens
06/27/1991WO1991009122A1 A recombinant human factor viii derivative
06/27/1991WO1991009116A1 Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus
06/27/1991WO1991009114A1 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product
06/27/1991WO1991009113A1 Synthetic polypeptide with type iv collagen activity
06/27/1991WO1991009059A1 Antibody antagonists of human interleukin-4
06/27/1991WO1991009058A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
06/27/1991WO1991009057A1 Novel proteins with oncostatin m activity and process for their preparation
06/27/1991WO1991009056A1 Octapeptide analogs of somatostatin having threonine at the sixth position
06/27/1991WO1991009055A1 Acylated bradykinin antagonists and uses therefor
06/27/1991WO1991009051A1 Substituted cyclic penicillanic acid tetrapeptides
06/27/1991WO1991008772A1 Improved meningococcal polysaccharide conjugate vaccine
06/27/1991WO1991008768A1 Anistreplase for treating stroke
06/27/1991WO1991008765A1 Stabilization of k2p pro
06/27/1991WO1991008762A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
06/27/1991WO1991008761A1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof
06/27/1991WO1991008760A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
06/27/1991WO1991008759A1 Alkyl substituted cyclic penicillanic acid pentapaptides
06/27/1991WO1991008758A1 Wound treatment employing biologically active peptides
06/27/1991WO1991008756A1 Novel malarial sporozoite peptide antigens
06/27/1991WO1991008754A1 Medicinal application of m-csf
06/27/1991WO1991008753A1 Method and composition for the treatment of mammalian hiv infection
06/27/1991WO1991008746A1 Killing of activated lymphocytes
06/27/1991WO1991007437A3 Improved cd-30 antibodies and fragments thereof
06/27/1991DE3942446A1 Compsn. for treating psoriasis and neuro-dermatitis - contains healing earth, royal jelly and flower pollen
06/27/1991DE3942145A1 T-pa-solubilisierung T-pa-solubilization
06/27/1991DE3942144A1 Stabilisierung von k1k2p pro Stabilization of K1K2P per
06/27/1991DE3942143A1 T-pa pro stabilisierung T-pa per stabilization
06/27/1991DE3942142A1 Stabilisierung von glykosyliertem t-pa Stabilization of glycosylated t-pa
06/27/1991DE3942141A1 K2p pro-stabilisierung K2p pro-stabilization
06/27/1991CA2072017A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof
06/27/1991CA2070660A1 Cell-cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
06/27/1991CA2070171A1 Proteins with oncostatin m activity and process for their preparation
06/27/1991CA2046594A1 Octapeptide analogs of somatostatin having threonine at the sixth position
06/27/1991CA2006744A1 Nucleid acids and polypeptides encoded thereby
06/26/1991WO1991009612A1 Tumor cell growth inhibitor
06/26/1991EP0434625A2 IGF-I for treating adverse effect of steroid therapy
06/26/1991EP0434605A2 Novel process for the production of unfused protein in E. coli
06/26/1991EP0434560A1 New derivatives of substituted aminoacids, process for their preparation and pharmaceutical compositions containing them
06/26/1991EP0434445A2 Process to obtain new mixed copper aminoacidate complexes from phenanthrolines and their alkyl derivatives to be used as anticancerigenic agents
06/26/1991EP0434369A1 New benzodiazepine analogs
06/26/1991EP0434364A2 Benzodiazepine analogs for treating panic syndrome and for directly inducing analgesia
06/26/1991EP0434360A1 New benziodiazepine analogs
06/26/1991EP0433827A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
06/26/1991EP0433765A1 The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy
06/26/1991EP0433744A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration
06/26/1991EP0433442A1 Hybrid molecules
06/26/1991EP0433427A1 Combined use of n-imidazolyl derivatives of bicyclic compounds and cyclosporine in therapy
06/26/1991EP0433402A1 Therapeutic compounds, compositions and uses thereof
06/26/1991EP0433395A1 Stable bioactive somatotropins
06/26/1991EP0433390A1 Swine growth promotion
06/26/1991EP0433360A1 Improvements relating to the production of prodrugs.
06/26/1991EP0433353A1 Method and composition for the treatment and prevention of viral infections
06/26/1991EP0433276A1 Growth hormone related peptide
06/26/1991CN1052506A Recombinant japanese encephalitis molecules and methods of use therefor
06/26/1991CN1052483A Improvements in or relating to glycopeptide derivatives
06/26/1991CN1052482A 氨基酸衍生物 Amino acid derivatives
06/26/1991CA2044621A1 Inhibiting agent against the proliferation of tumour cells
06/25/1991US5026839 Angiogenesis, mitotic and chemotaxic activity; stimulation of protease synthsis; equivalent to factors from human placenta
06/25/1991US5026826 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
06/25/1991US5026825 With aminolevulinic acid
06/25/1991US5026703 Peptide oxytocin antagonists
06/25/1991US5026686 Antiviral peptides
06/25/1991US5026685 Hypotensive agents
06/25/1991US5026639 Method to improve mRNA translation and use thereof for production of platelet factor-4
06/25/1991US5026544 Methods and compositions for inhibiting the growth of neoplastic cells
06/23/1991WO1991009947A1 Polypeptides having serine protease inhibitor activity and dna coding therefor
06/23/1991WO1991009945A1 Neutrophil chemoattractants
06/23/1991WO1991009871A1 Hybrid molecules having translocation region and cell-binding region
06/23/1991WO1991009610A1 Fibroblast growth factor for use in the prevention and treatment of viral infections
06/23/1991CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
06/23/1991CA2072012A1 Neutrophil chemoattractants
06/23/1991CA2071969A1 Hybrid molecules having translocation region and cell-binding region
06/23/1991CA2070399A1 Polypeptides and dna coding therefor
06/23/1991CA2047203A1 Fibroblast growth factor for use in the prevention and treatment of viral infections
06/23/1991CA2033140A1 Thrombolytically acting combined preparation
06/23/1991CA2033042A1 Methods for diagnosis of tuberculosis
06/22/1991WO1991009968A1 Cd3 specific recombinant antibody
06/22/1991WO1991009965A1 An improved toxin for construction of immunotoxins
06/22/1991CA2071946A1 Toxin for construction of immunotoxins
06/22/1991CA2030005A1 Pharmaceutical composition with anti-inflammatory activity
06/21/1991WO1991009127A1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g)
1 ... 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 ... 3163